Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-04-25 @ 7:56 PM
Study NCT ID:
NCT02986594
Status:
UNKNOWN
Last Update Posted:
2016-12-09
First Post:
2016-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla
Sponsor:
Shanghai First Maternity and Infant Hospital
Organization:
Study Overview
Official Title:
Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine
Status:
UNKNOWN
Status Verified Date:
2016-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this clinical cohort study, the investigators observe the efficacy of low molecular weight heparin in the treatment of thrombophilia with recurrent pregnancy loss with a prospective randomized controlled trial.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: